FindTrial
Sign In

Early diagnostic value of hepcidin in critically ill patients with sepsis.

Early diagnostic value of hepcidin in critically ill patients with sepsis.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDD-16008522
Enrollment
Unknown
Registered
2016-05-23
Start date
2016-06-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Interventions

Gold Standard:
Index test:

Sponsors

Zhoupu Hospital Affiliated to Shanghai University of Medicine and Health Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Admitted to our hospital ICU patients with clinical suspicious/confirmed infections, or the quick sepsis related organ failure assessment(qSOFA) >=2.

Exclusion criteria

Exclusion criteria: 1) aged less than 18 years old; 2) Hb less than 10g/dL; 3) Malignant tumor or acquired immunodeficiency syndrome.

Design outcomes

Primary

MeasureTime frame
hepcidin;—

Countries

China

Contacts

Public ContactQiu Zeliang

Zhoupu Hospital Affiliated to Shanghai University of Medicine & Health Sciences

zlqiu1121@163.com+86 18121216112

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 23, 2026